Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 17,666 |
| Other current assets | 1,221 |
| TOTAL | $18,887 |
| Non-Current Assets | |
| PPE Net | 24 |
| Other Non-Current Assets | 1,084 |
| TOTAL | $1,108 |
| Total Assets | $19,993 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 634 |
| Accrued Expenses | 1,971 |
| Other current liabilities | 61 |
| TOTAL | $2,665 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 20 |
| TOTAL | $20 |
| Total Liabilities | $2,685 |
| Shareholders' Equity | |
| Common Shares | 42 |
| Retained earnings | -24,549 |
| TOTAL | $17,307 |
| Total Liabilities And Equity | $19,992 |